Offer - Urjas Oil for just ₹ 1 X
Isosorbide Dinitrate + Hydralazine is an allopathic medicine The correct dosage of Isosorbide Dinitrate + Hydralazine depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Isosorbide Dinitrate + Hydralazine is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Isosorbide Dinitrate + Hydralazine is used -
Moderate
Mild
Common
Is the use of Isosorbide Dinitrate + Hydralazine safe for pregnant women?
Isosorbide Dinitrate + Hydralazine can have harmful effects in pregnant women. If you experience any discomfort after using Isosorbide Dinitrate + Hydralazine, then discontinue the use and take your doctor's advice.
Is the use of Isosorbide Dinitrate + Hydralazine safe during breastfeeding?
Isosorbide Dinitrate + Hydralazine is completely safe for breastfeeding women.
What is the effect of Isosorbide Dinitrate + Hydralazine on the Kidneys?
Isosorbide Dinitrate + Hydralazine rarely harms the kidneys.
What is the effect of Isosorbide Dinitrate + Hydralazine on the Liver?
Isosorbide Dinitrate + Hydralazine may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Isosorbide Dinitrate + Hydralazine on the Heart?
Very few cases of side effects of Isosorbide Dinitrate + Hydralazine on the heart have been reported.
Isosorbide Dinitrate + Hydralazine should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Isosorbide Dinitrate + Hydralazine unless your doctor advises you to do so -
Is this Isosorbide Dinitrate + Hydralazine habit forming or addictive?
No, there is no any evidence that Isosorbide Dinitrate + Hydralazine is addictive.
Interaction between Food and Isosorbide Dinitrate + Hydralazine
You can take Isosorbide Dinitrate + Hydralazine with food.
Interaction between Alcohol and Isosorbide Dinitrate + Hydralazine
No research has been done on this till date. Therefore, it is not known what the effect of taking Isosorbide Dinitrate + Hydralazine with alcohol will be.
Yes, Isosorbide Dinitrate + Hydralazine might lower heart rate (bradycardia) in some cases usually when the drug is taken in more than the recommended doses or if the patient has some medical condition such as hypovolemia.
Take oral Isosorbide Dinitrate + Hydralazine as long as it is recommended by your doctor.
Yes, Isosorbide Dinitrate + Hydralazine may cause a headache. It is a common side effect of this drug. However, the exact cause of a headache is unknown. If you experience a severe headache after taking this drug, take a mild painkiller, apply balm and complete rest even after this if the pain does not subside then discuss with your doctor immediately.
Yes, Isosorbide Dinitrate + Hydralazine is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as a headache and lightheadedness. If you experience above-mentioned side effects after taking this medicine then inform your doctor and follow his/her instructions.
Yes, Isosorbide Dinitrate + Hydralazine can help with chest pain. It is used to prevent chest pain in patients with coronary artery disease.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Isordil® Titradose™ (isosorbide dinitrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 543-544
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 653-654
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydralazine hydrochloride
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 566-567
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 651-653